•
Jun 27, 2020

Thermo Fisher Q2 2020 Earnings Report

Thermo Fisher Scientific reported an extraordinary quarter, leveraging its scale and expertise to meet strong global demand for COVID-19 products and services.

Key Takeaways

Thermo Fisher Scientific's second quarter revenue increased by 10% to $6.92 billion, driven by strong demand for COVID-19 related products and services. Adjusted EPS increased 28% to $3.89.

Second quarter revenue increased 10% to $6.92 billion.

Second quarter GAAP diluted earnings per share (EPS) increased 5% to $2.90.

Second quarter adjusted EPS increased 28% to $3.89.

Generated approximately $1.3 billion of COVID-related revenue.

Total Revenue
$6.92B
Previous year: $6.32B
+9.5%
EPS
$3.89
Previous year: $3.04
+28.0%
Gross Profit
$3.5B
Previous year: $2.82B
+24.0%
Cash and Equivalents
$5.82B
Previous year: $2.29B
+154.3%
Free Cash Flow
$1.62B
Previous year: $1.07B
+50.7%
Total Assets
$61.6B
Previous year: $58B
+6.2%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher Scientific did not provide GAAP financial measures on a forward-looking basis because they are unable to predict with reasonable certainty and without unreasonable effort items such as the timing and amount of future restructuring actions and acquisition-related charges as well as gains or losses from sales of real estate and businesses, the early retirement of debt and the outcome of legal proceedings.

Revenue & Expenses

Visualization of income flow from segment revenue to net income